DC Chemicals · Product datasheet

Sotorasib racemate — Datasheet

CAT. NO. DCC0593

Product page and current package options

ParameterValue
Chemical NameCID 137278711
CAS No.2252403-56-6
SynonymsAMG-510;AMG510;AMG 510;6-fluoro-7-(2-fluoro-6-hydroxyphenyl)-1-(4-methyl-2-propan-2-ylpyridin-3-yl)-4-[(2S)-2-methyl-4-prop-2-enoylpiperazin-1-yl]pyrido[2,3-d]pyrimidin-2-one;AMG510 racemate;Kras G12C inhibitor 9;2B2VM6UC8G;GTPL10678;BCP30452;BCP33368;s8830;DB15569;4-((S)-4-Acryloyl-2-methylpiperazin-1-yl);CID 137278711;Sotorasib racemate
FormulaC30H30F2N6O3
M.Wt560.5944
SMILESFC1=C(C2C(=C([H])C([H])=C([H])C=2O[H])F)N=C2C(=C1[H])C(=NC(N2C1=C(C([H])([H])[H])C([H])=C([H])N=C1C([H])(C([H])([H])[H])C([H])([H])[H])=O)N1C([H])([H])C([H])([H])N(C(C([H])=C([H])[H])=O)C([H])([H])[C@]1([H])C([H])([H])[H]
Purity>99%
Storage2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO

Biological Activity

Sotorasib racemate (Compound A) is an orally active racemate of Sotorasib, a covalent inhibitor of KRAS G12C mutant which induces adaptive feedback activation of MAPK pathway. Sotorasib racemate also exerts inhibitor activity against KRAS G12C induced cancer and can be applied to cancer research.

In Vitro

No in vitro data are provided in the current product source. Contact us for further information.

In Vivo

No in vivo data are provided in the current product source. Contact us for further information.

References & source

DC Chemicals original product information

Published experimental findings depend on the model and assay conditions. They do not guarantee equivalent performance in every application. For laboratory research use only.

Cart

Request quotation